These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27167389)

  • 1. Open innovation.
    Hodson R
    Nature; 2016 May; 533(7602):S53. PubMed ID: 27167389
    [No Abstract]   [Full Text] [Related]  

  • 2. The importance of patent sharing in neglected disease drug discovery.
    Edlin C
    Future Med Chem; 2011 Sep; 3(11):1331-4. PubMed ID: 21879838
    [No Abstract]   [Full Text] [Related]  

  • 3. Tropical disease: A neglected cause.
    Laursen L
    Nature; 2016 May; 533(7602):S68-9. PubMed ID: 27167396
    [No Abstract]   [Full Text] [Related]  

  • 4. A new chapter in innovation.
    Holmes D
    Nature; 2016 May; 533(7602):S54-5. PubMed ID: 27167390
    [No Abstract]   [Full Text] [Related]  

  • 5. Open Access Could Transform Drug Discovery: A Case Study of JQ1.
    Arshad Z; Smith J; Roberts M; Lee WH; Davies B; Bure K; Hollander GA; Dopson S; Bountra C; Brindley D
    Expert Opin Drug Discov; 2016; 11(3):321-32. PubMed ID: 26791045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Product development programs for neglected tropical diseases: A crucial role for expert meetings.
    Hussaarts L; van der Weijde K; Dome P; Kourany-Lefoll E; Reinhard-Rupp J; de Vrueh R;
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005183. PubMed ID: 28231243
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter from the editor.
    Rabasseda X
    Drugs Today (Barc); 2015 Jan; 51(1):5. PubMed ID: 26960244
    [No Abstract]   [Full Text] [Related]  

  • 8. Understanding and creating value from open source drug discovery for neglected tropical diseases.
    Allarakhia M; Ajuwon L
    Expert Opin Drug Discov; 2012 Aug; 7(8):643-57. PubMed ID: 22657529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WIPO Re:Search: a consortium catalyzing research and product development for neglected tropical diseases.
    Dent J; Ramamoorthi R; Graef K; Nelson LM; Wichard JC
    Pharm Pat Anal; 2013 Sep; 2(5):591-6. PubMed ID: 24237166
    [No Abstract]   [Full Text] [Related]  

  • 10. Eliminating neglected diseases in poor countries: a conversation with Andrew Witty. Interview by Susan Dentzer.
    Witty A
    Health Aff (Millwood); 2009; 28(3):w411-6. PubMed ID: 19299425
    [No Abstract]   [Full Text] [Related]  

  • 11. Twelve principles for open innovation 2.0.
    Curley M
    Nature; 2016 May; 533(7603):314-6. PubMed ID: 27193662
    [No Abstract]   [Full Text] [Related]  

  • 12. How informatics can potentiate precompetitive open-source collaboration to jump-start drug discovery and development.
    Perakslis ED; Van Dam J; Szalma S
    Clin Pharmacol Ther; 2010 May; 87(5):614-6. PubMed ID: 20376001
    [No Abstract]   [Full Text] [Related]  

  • 13. Patent-sharing scheme for neglected diseases may have catch.
    Waters H
    Nat Med; 2011 Dec; 17(12):1529. PubMed ID: 22146436
    [No Abstract]   [Full Text] [Related]  

  • 14. Financing and collaboration on research and development for nodding syndrome.
    Årdal C; Røttingen JA
    Health Res Policy Syst; 2016 Mar; 14():19. PubMed ID: 26983551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsoft's purchase of GitHub leaves some scientists uneasy.
    Silver A
    Nature; 2018 Jun; 558(7710):353. PubMed ID: 29921852
    [No Abstract]   [Full Text] [Related]  

  • 16. Open-source approaches for the repurposing of existing or failed candidate drugs: learning from and applying the lessons across diseases.
    Allarakhia M
    Drug Des Devel Ther; 2013; 7():753-66. PubMed ID: 23966771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collaborating with our community to increase code sharing.
    Cadwallader L; Papin JA; Mac Gabhann F; Kirk R
    PLoS Comput Biol; 2021 Mar; 17(3):e1008867. PubMed ID: 33784294
    [No Abstract]   [Full Text] [Related]  

  • 18. EFPIA-PhRMA's principles for clinical trial data sharing have been misunderstood.
    Doshi P
    BMJ; 2013 Aug; 347():f5164. PubMed ID: 23963563
    [No Abstract]   [Full Text] [Related]  

  • 19. Traditional drug-discovery model ripe for reform.
    Cressey D
    Nature; 2011 Mar; 471(7336):17-8. PubMed ID: 21368796
    [No Abstract]   [Full Text] [Related]  

  • 20. Ask the experts.
    Pecoul B; Pollastri M; McKerrow J; Bueno-Calderon JM
    Future Med Chem; 2012 Jul; 4(11):1383-9. PubMed ID: 22857528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.